CAR T-Cell Therapy a ‘Really Exciting’ Development in Treatment of Lymphomas

preview_player
Показать описание
The evolution of CAR T-cell therapy has been an exciting development for the treatment of all lymphomas, including mantle cell lymphoma, according to Dr. Ian Flinn.

In an interview with CURE®, Flinn, director of lymphoma research at Sarah Cannon Research Institute, discussed the use of CAR T cells to treat lymphomas, as well as how the ZUMA-2 trial is shaping up to influence the treatment of patients with mantle cell lymphoma.


CURE: Combining science and humanity to make cancer understandable.
Рекомендации по теме